Boom­ing Mod­er­na is rais­ing $600M while ramp­ing up man­u­fac­tur­ing and clin­i­cal stud­ies

Ever since Flag­ship launched Mod­er­na back in 2012 with a $40 mil­lion round, the biotech has been a per­pet­u­al mon­ey-rais­ing ma­chine, gar­ner­ing well over a bil­lion dol­lars from an avid group of in­vestors and part­ners look­ing to par­tic­i­pate in its promised drug R&D rev­o­lu­tion. And now in a fil­ing with the SEC, the com­pa­ny has out­lined its lat­est big ef­fort to add $600 mil­lion to its cof­fers, with most of the cash al­ready in hand.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER